Evidence for beneficial effect of recombinant interleukin-2 in HIV-associated B lymphoma.
P
P
Mazza
M
M
Bocchia
S
S
Tura
F
F
Tumietto
P
P
Costigliola
O
O
Coronado
E
E
Ricchi
F
F
Chiodo
D015658:HIV Infections / Q000150:complications*; D006716:Homosexuality; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D016393:Lymphoma, B-Cell / Q000150:complications / Q000188:drug therapy*; D008297:Male; D010996:Pleural Effusion; D011994:Recombinant Proteins / Q000627:therapeutic use; D015215:Zidovudine / Q000627:therapeutic use
D007376:Interleukin-2; D011994:Recombinant Proteins; D015215:Zidovudine